Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1695758

registered interest
date	13/03/2024
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Advanced Therapy Medicinal Products: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to help support research into cell and gene therapy in Scotland.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	18416
answer	answer is ministerial correction date of answer 22/03/2024 answer text <p>The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult (CGTC).</p><p> </p><p>DSIT also invested £10 million - alongside £10 million from Scottish Enterprise – to support a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Glasgow.</p><p> </p><p>The Vaccine Taskforce provided funding for a state-of-the art CGTC facility in Braintree to accelerate the development and manufacturing of advanced therapies at clinical and commercial scale.</p><p> </p><p>My department also supported CGTC to establish apprenticeships and training programmes to upskill people across the UK.</p> answering member constituency Arundel and South Downs answering member printed Andrew Griffith question first answered 22/03/2024 09:30:33 answering member 4874 label Biography information for Andrew Griffith
tabling member	3966 label Biography information for Ian Murray

1695759

registered interest
date	13/03/2024
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Advanced Therapy Medicinal Products: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to increase Scotland’s (a) manufacturing capacity for and (b) delivery of cell and gene therapies.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	18417
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The government is investing significantly to support manufacturing and delivery of cell and gene therapies.</p><p /><p>Since 2021, government has launched three UK-wide capital grant schemes – up to £118 million of funds – to incentivise manufacturing investments, including in advanced therapies. Last year, government announced a further £520 million to increase investment in Life Sciences manufacturing.</p><p> </p><p>The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult which also coordinates the Advanced Therapy Treatment Centre network.</p><p> </p> answering member constituency Arundel and South Downs answering member printed Andrew Griffith question first answered 21/03/2024 09:26:38 answering member 4874 label Biography information for Andrew Griffith
tabling member	3966 label Biography information for Ian Murray

1642781

registered interest
date	07/06/2023
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Life Sciences: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to support the life sciences sector in Scotland.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	188440
answer	answer is ministerial correction date of answer 16/06/2023 answer text <p>On 26 May we announced a raft of measures to support the life sciences sector across the UK. This includes a new Biomanufacturing Fund, open to companies across the UK, and measures to improve the underlying business environment such as through pro-innovation review of technologies (life sciences), which will give industry and investors the certainty they need to drive innovation, investment and growth. We will ensure the sector has the finance it needs to grow through our Life Sciences Investment Envoy, Dan Mahony, and the Long-term Investment For Technology and Science (LIFTS) initiative, bolstering investment in companies across the UK.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/06/2023 12:09:18 answering member 4020 label Biography information for George Freeman
tabling member	3966 label Biography information for Ian Murray

1642386

registered interest
date	06/06/2023
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Science: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, whether her Department plans to collaborate with businesses in the Scottish life sciences industry to meet the Government’s ambition of being a science superpower by 2030.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	187938
answer	answer is ministerial correction date of answer 20/06/2023 answer text <p>The Department collaborates closely with companies from across the UK, including Scottish industry, to deliver the Life Sciences Vision and ensure we deliver on our science superpower ambitions. Officials in the Office for Life Sciences meet with the Devolved Administrations monthly, and they are officially represented on the quarterly Life Sciences Delivery Board to ensure we are delivering for the entirety of the UK. Representatives from Scottish Industry also attended the recent ‘Treasury Connect’ series, where Ministers and officials met directly with industry to discuss their ambition and concerns. This directly informed the £650 million package announced on 26 May.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/06/2023 08:01:23 answering member 4020 label Biography information for George Freeman
tabling member	3966 label Biography information for Ian Murray

1642388

registered interest
date	06/06/2023
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Life Sciences: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, what steps her Department has taken to help increase the number of life sciences companies in Scotland.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	187940
answer	answer is ministerial correction date of answer 14/06/2023 answer text <p>Through the Life Sciences Vision, we are committed to growing the life sciences sector across the country. We have delivered a range of programmes open to companies across the UK, including the Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF) in 2021, the Life Sciences Innovative Manufacturing Fund (LSIMF) in 2022, and the Biomanufacturing Fund announced on 26 May this year. We appointed a Life Sciences Investment Envoy, Dan Mahony, to boost investment in companies looking to grow and are working with the Treasury on the Long-term Investment For Technology and Science (LIFTS) initiative to crowd-in investment and grow the sector.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 14/06/2023 12:04:49 answering member 4020 label Biography information for George Freeman
tabling member	3966 label Biography information for Ian Murray